Inari Medical, Inc. (NARI)

USD 55.03

(-2.01%)

Market Cap (In USD)

3.22 Billion

Revenue (In USD)

493.63 Million

Net Income (In USD)

-1.63 Million

Avg. Volume

889.81 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
36.73-66.61
PE
-
EPS
-
Beta Value
0.963
ISIN
US45332Y1091
CUSIP
45332Y109
CIK
1531048
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Andrew J. Hykes
Employee Count
-
Website
https://www.inarimedical.com
Ipo Date
2020-05-22
Details
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.